English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45279/58455 (77%)
造訪人次 : 2490980      線上人數 : 168
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋


    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/1169


    題名: Effect of silymarin on hepatic function of patients with unresectable hepatocellular carcinoma after transcatheter hepatic arterial chemoembolization
    作者: 李志明;邱仲峰;梁庭繼
    Lee CM;Leung TK;Chang CC;Kuo YC;Chiou JF;Wang HJ;Chen YY
    貢獻者: 醫學系放射線學科
    日期: 2008
    上傳時間: 2009-08-14 12:58:32 (UTC+8)
    摘要: 經肝動脈栓塞合併化學治療是治療無法切除之肝腫瘤常用的方法。Silymarin是水飛薊植物的衍生物，它被廣泛地使用在慢性肝疾病上。在台灣，有一些醫師會建議病患在進行經肝動脈栓塞合併化學治療後，服用silymarin來作為保肝劑。本研究探討silymarin在此模式下之有效性。本研究共有244位接受經肝動脈栓塞合併化學治療之病患，這些病患在術前之Child-Pugh classification皆無顯著差異。其中111位在經肝動脈栓塞合併化學治療後，每日服用280毫克的silymarin持續兩週，另外133位在治療後不服用silymarin。紀錄病患術前、術後第二、四、六天及二、三、四、五週之肝功能相關數據。結果顯示，兩組病患之肝功能（包括ALT、AST、鹼性磷酸酶、總膽紅素、白蛋白、乳糖脫氫酶）在各個不同的時間點時，皆無顯著差異。每日服用280毫克的silymarin持續兩週，並不能顯著改善經肝動脈栓塞合併化學治療後病患之肝功能，顯示silymarin投與之劑量及時間長短須經更嚴密的設計。
    Transcatheter hepatic arterial chemoembolization (TACE) is common treatment for unresectable hepatocellular carcinoma. Silymarin, derived from milk thistle, is widely used internationally for chronic liver disease. Some Taiwanese physicians prescribe silymarin as a hepatoprotective agent after TACE, although there is no evidence on its efficacy in this setting. Retrospectively compare two groups of patient undergoing TACE at our institution: 111 given silymarin postoperatively and 133 who underwent the same procedure and received similar postoperative care but were not given silymarin. The postoperative liver function was evaluated. Patients prescribed silymarin took 280 mg orally daily for two weeks. Liver function tests were checked at baseline and on post-TACE days 2, 4, and 6 and weeks 2-5. Groups were comparable for age, gender, and Child-Pugh class. There were no significant differences between the two groups at different time points in serum levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total bilirubin, albumin and lactate dehydrogenase. Oral silymarin did not accelerate recovery of hepatic function following TACE; there is no basis for its use in this setting.
    關聯: Chin J Radiol.(33):137-141.
    資料類型: article
    顯示於類別:[放射線學科] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    H-10.pdf336KbAdobe PDF143檢視/開啟
    全文.txt0KbText198檢視/開啟
    摘要.pdf71KbAdobe PDF149檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice

    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏，包含體系內各式學術著作及學術產出。秉持開放取用的精神，提供使用者進行資料檢索、下載與取用，惟仍請適度、合理地於合法範圍內使用本平台之內容，以尊重著作權人之權益。商業上之利用，請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台，視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例，並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者，煩請權利人通知本平台維護人員([email protected])，將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋